Dual epigenetic modifiers for cancer therapy

Area of Science:

• Epigenetics
• Drug Discovery
• Oncology

Background:

• Epigenetic modifications play a crucial role in cancer development.
• Targeting epigenetic enzymes is a promising therapeutic strategy.

Purpose of the Study:

• To discover and characterize novel dual inhibitors of G9a/EHMT2 and DNA methyltransferases.
• To evaluate the in vivo efficacy of these inhibitors in human tumors.

Main Methods:

• Development of first-in-class dual reversible inhibitors.
• In vivo studies using human tumor models.

Main Results:

• Discovery of potent dual inhibitors targeting G9a/EHMT2 and DNA methyltransferases.
• Demonstrated in vivo efficacy in human tumors.

Conclusions:

• Dual inhibition of G9a/EHMT2 and DNA methyltransferases represents a viable epigenetic drug discovery approach.
• These findings support further investigation for cancer therapy.